Enrico Vasile

MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity

Elisa Giovannetti, Niccola Funel, Godefridus J. Peters et al. · Cancer Research · 2010 · 453 citations · Full text

Pancreatic Cancer, Medicine, Gemcitabine Resistance +13

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC

Marzia Del Re, Riccardo Marconcini, G. Pasquini et al. · British Journal of Cancer · 2018 · 242 citations · Full text

Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases

Gianluca Masi, Fotios Loupakis, Luca Emanuele Pollina et al. · Annals of Surgery · 2009 · 234 citations

Correlation of <i>CDA, ERCC1</i>, and <i>XPD</i> Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

Carmelo Tibaldi, Elisa Giovannetti, Enrico Vasile et al. · Clinical Cancer Research · 2008 · 207 citations

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study

Alessandro Russo, Marco Russano, Tindara Franchina et al. · Advances in Therapy · 2020 · 165 citations

Medicine, Immunology, Hematology +9